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ABSTRACT 
Effects of the estrous cycle on neuronal activation in the 
bed nucleus of the stria terminalis of fear-conditioned female rats 
 
Barbara Tsao 
Department of Veterinary Medicine and Biomedical Sciences 
Texas A&M University 
 
Research Advisor: Dr. Naomi Nagaya 
Department of Psychology 
 
Women are much more likely than men to develop trauma- and anxiety-related disorders over 
their lifetime. One possible contributing factor is that unlike men, women experience large 
fluctuations in ovarian steroid hormones, like progesterone. Previous studies have suggested that 
high levels of progesterone reduce the expression of fear in female rats. The effect may be 
derived from allopregnanolone (ALLO), a metabolite of progesterone. ALLO, a positive 
allosteric modulator of ɣ-aminobutyric acid type A (GABAA) receptors, may influence activity in 
the bed nucleus of the stria terminalis (BNST), a brain area that is important for the expression of 
conditioned fear. GABA is the major inhibitory neurotransmitter in the brain and contributes to 
the suppression of anxiety responses. The proposed study seeks to determine the effect of 
fluctuating progesterone levels on BNST cell activation during the expression of conditioned fear 
in female rats. We hypothesize that rats tested when progesterone levels are high will have lower 
BNST cell activation compared to rats tested when progesterone levels are low. To this end, 
animals will be trained and tested at estrous cycle stages with either high or low levels of 
progesterone under the Pavlovian fear conditioning paradigm. Progesterone levels will be 
measured using blood samples. BNST cell activation will be measured by quantifying the 
number of c-fos-expressing cells within this brain region. By exploring how progesterone 
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influences BNST cell activation during conditioned fear, a greater understanding of the 
susceptibility of women to trauma- and stress-related disorders, such as posttraumatic stress 
disorder (PTSD), may be achieved. 
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NOMENCLATURE 
 
ALLO  allopregnanolone 
GABAA ɣ-aminobutyric acid type A  
BNST  bed nucleus of the stria terminalis  
PTSD  posttraumatic stress disorder 
Pro  animals in proestrus during training or testing 
Di  animals in diestrus during training or testing 
ITI  inter-trial interval  
ELISA  enzyme-linked immunosorbent assay 
PBS-Az phosphate-buffered saline azide  
NSB  nonspecific binding 
Bo  maximum binding 
pNpp  p-nitrophenyl phosphate 
DAB-nickel nickel intensified diaminobenzidine  
PBS  phosphate-buffered saline 
PBST  phosphate-buffered saline with Tween-20 
ABC  Avidin-Biotin Complex 
ANOVA analysis of variance  
OV  oval  
JU  juxtacapsular  
ALD  anterolateral, dorsal portion  
AMD   anteromedial, dorsal potion  
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ALV  anterolateral, ventral portion  
AMV  anteromedial, ventral portion  
FU  fusiform  
AL   anterolateral  
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CHAPTER I 
INTRODUCTION 
 
A study accounting for the effects of the estrous cycle may shed further light upon the unique 
gender differences that exist in trauma- and stress-related disorders. For example, the prevalence 
of anxiety and depression is greater in women than in men (Leach et al., 2008). Furthermore, 
twice as many females are diagnosed with PTSD than males (Christiansen and Hansen, 2015). 
Possessing an in-depth understanding of how various hormones engage with and affect the brain 
is an imperative step towards developing future solutions to counter trauma- and stress-related 
disorders. Past studies have demonstrated significant sex differences in rats with respect to 
contextual fear (Maren et al., 1994). In particular, the stages of the estrous cycle have been 
shown to influence the expression of contextual fear (Markus and Zecevic, 1997). Additional 
reports have shown that the presence of allopregnanolone (ALLO), a metabolite of progesterone, 
is associated with reduced fear in female rats (Frye et al., 2000; Nagaya et al., 2015). Indeed, it 
has been generally indicated that the female sex bias existent in anxiety disorders is attributed to 
the complexity and fluctuations of female hormonal cycles (Donner and Lowry, 2013). To 
explore the effects of hormone fluctuations in females on conditioned contextual fear, the estrous 
cycle of female rodents serves as an excellent model. To understand how hormones affect the 
brain, one must understand the regions they target. In regards to the study of anxiety, particular 
interest has been brought to the bed nucleus of the stria terminalis (BNST). This brain region has 
been recognized for its involvement in the expression of fear (Jennings et al., 2013) and is 
hormonally regulated (Claro et al., 1995). Due to these findings, there is reason to believe that 
the fear-reducing effects of ALLO may be linked to reduced activation in the BNST. By 
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examining how progesterone affects neuronal activation in the BNST during the expression of 
conditioned fear, existing therapy for trauma- and stress-related disorders could be made more 
effective. 
 
Objectives 
Our objective is to evaluate how progesterone influences neuronal activation in the BNST during 
expression of conditioned fear in normal cycling female rats. We hypothesize that high levels of 
progesterone, which are representative of high levels of ALLO, will result in reduced activation 
of BNST neurons during the expression of conditioned contextual fear. 
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CHAPTER II 
METHODS 
 
Animals 
 
In total, 82 female, Long-Evans rats (200-250 g; Harlan Laboratories, Indianapolis, Indiana) 
were used for this study. Each animal was individually housed in a clear plastic cage with 
unlimited access to food and water. The holding room followed a 14:10 h light: dark cycle and 
contained no other subjects for the duration of the experiment. The rats were handled for four 
days prior to smearing procedures to accustom them to the experimenter’s touch. 
 
 
Vaginal smears 
For 2 complete cycles before behavioral procedures and continuing throughout behavioral 
procedures, vaginal smears were taken and characterized daily from the female rats between the 
hours of 11:00 am and 1:00 pm. This was done in order to predict the stages for each subject’s 
estrous cycle. Smears were taken using a cotton swab moistened with distilled water. For each 
animal, the cotton swab penetrated the vagina approximately 1 cm to catch cell samples. These 
cell samples were smeared onto glass slides and observed for morphology using light 
microscopy. Figure 1 illustrates sample vaginal smears of all 4 estrous cycle stages. Nucleated 
cells indicated proestrus, cornified cells indicated estrus, and a mixture of both cell types 
complimented by the presence of leukocytes indicated metestrus and diestrus. Metestrus (also 
known as diestrus 1) exhibits a more even distribution of the 3 cell types whereas diestrus (also 
known as diestrus 2) predominantly exhibits leukocytes. As shown in Figure 2, a normal rat 
estrous cycle lasts for 4 to 5 days: 1 day of proestrus, 1-2 days of estrus, and 2 days of 
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metestrus/diestrus. The lowest levels of progesterone occur during diestrus, while the highest 
levels of progesterone occur in proestrus. Upon review of the smears after two weeks, only 
subjects with normal cycles were included in data analysis.  
 
 
Behavioral context 
 
Behavioral training and testing were conducted in 7 identical observation chambers with the 
dimensions 30 x 24 x 21 cm (Med Associates, St. Albans, Vermont). Cabinet walls blocked off 
each chamber’s view of other chambers. The chambers were composed of two aluminum 
sidewalls and a Plexiglas ceiling, back wall, and door. The floor was made up of rows of steel 
rods wired to a shock source and a steel tray underneath. The base of each chamber had a load 
cell platform, which measured the amount of immobility within the chamber. Before every 
behavioral procedure, the chamber interiors were wiped down with 1% acetic acid. During the 
behavioral procedures, speakers inside the chambers delivered the tone stimuli; the rods 
delivered the shock stimuli, the ventilation fans outside the chambers provided background 
noise, and the cage and room white lights were turned on.  
 
 
Procedures 
Each animal was assigned to 1 of 8 training-testing groups shown in Table 1. Rats assigned as 
proestrus (Pro) were predicted to have high levels of progesterone. Rats assigned as diestrus 
(Di) were predicted to have low levels of progesterone. The No-Shock group served as a control 
for the Shock group during fear conditioning. In behavioral training, the female rats were placed 
in the chambers and immediately observed through a live video feed. The whole training period 
included a 3-minute baseline period, 5 tone-shock pairings with a 1-minute inter-trial interval 
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(ITI) between each, and a final 1-minute wait period. Each tone was 10 seconds long at a 
frequency of 2 kHz and an intensity of 100 dB. Each shock was 2 seconds long at 1 mA. The 
control group was trained in the same conditioning conditions but excluding shock. Training 
was conducted in order to allow for the learned acquisition of fear for each animal. Behavioral 
testing began 1 normal cycle after training for each rat in the Pro, Pro and Di, Di groups; for 
rats in the Pro, Di group, training occurred after three estrous cycle stages whereas for rats in 
the Di, Pro group, training occurred after five estrous cycle stages. The context and handling 
procedures remained the same as that for training except with the absence of tones and shocks 
for all groups. The training and testing procedure is graphically illustrated in Figure 3. 
Behavioral testing was conducted in order to measure the level of fear retention from previous 
training. 
 
 
Histology 
 
Approximately 1 hour after behavioral testing, the subjects were euthanized with pentobarbital 
(100 mg/kg). Immediately upon death, blood was transcardially extracted from the animals and 
prepared for future enzyme-linked immunosorbent assay (ELISA) analysis. The rats were 
perfused with 0.1 M phosphate buffer solution followed by 0.1 M paraformaldehyde. The 
perfused brains were extracted and incubated in 4% formalin and then transferred to a 30% 
sucrose-formalin solution. After complete post-fixation, the brains were sliced in a cryostat and 
stored in 0.01% PBS/sodium azide (PBS-Az) before immunohistochemistry. 
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Enzyme-linked immunosorbent assay (ELISA) 
 
A progesterone ELISA kit (Enzo Life Sciences, Inc.) was used to measure plasma progesterone 
levels. This laboratory technique allowed us to correlate circulating progesterone levels with 
freezing behavior and neuronal activity within the BNST. Collected blood was centrifuged at 
1000 rpm for 10 minutes in order to collect the supernatant for the ELISA procedure. This 
supernatant was stored at -20 ˚C before use. Initially, 100 µl of Assay Buffer was pipetted into 
nonspecific binding (NSB) and maximum binding (Bo) wells. One hundred µl of 6 different 
standards and 100 µl of the supernatant from experimental samples were pipetted into the 
appropriate wells. All standards and samples were run in duplicate. Fifty µl of the Assay Buffer 
was pipetted into the NSB wells, followed by 50 µl of blue Conjugate for every well excluding 
the Blank and Total Activity wells. Fifty µl of yellow Antibody solution was added to each well 
except the Blank, Total Activity, and NSB wells. The wells were left to incubate at room 
temperature on a plate shaker at 500 rpm for 2 hours. Afterwards, the contents were removed and 
the wells were washed with 400 µl of wash solution 3 times. Once the wells dried after the 
washing, 5 µl of blue Conjugate was added to TA wells and 200 µl of p-nitrophenyl phosphate 
(pNpp) Substrate solution was added to every well. This solution was incubated for 45 minutes. 
Finally, 50 µl of Stop Solution was added to each well and analyzed by the PerkinElmer Victor 
X3 multimode plate reader at 405 nm. 
 
Immunohistochemical methods  
Brain sections were stained with antibodies and nickel intensified diaminobenzidine (DAB- 
nickel) for the black staining of c-fos. C-fos is an immediate early gene protein that reflects 
neuronal activation. By utilizing this immunohistochemical procedure, we were able to visualize 
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the number and location of cells activated in the BNST during either the expression of 
conditioned contextual fear or as a result of re-exposure to a context that had been paired with 
tone presentations.  
 
BNST sections of the brain were rinsed in a 12-well staining plate on a shaker with phosphate- 
buffered saline (PBS) for 10 seconds, followed by incubation in 0.3% H2O2 (10 µl of 30% H2O2 
per mL PBS) for 15 minutes. Then, the sections were rinsed in PBS 3 times and incubated in the 
primary antibody, a polyclonal rabbit anti-c-Fos antibody (Millipore PC05; 1:10,000 in PBS-
Tween; PBST), overnight. The next day the sections were rinsed in PBS 3 times and incubated in 
the secondary antibody, Alexa Fluor 488 biotinylated donkey anti-rabbit (1 µl per 1 mL PBST), 
for 1 hour. The sections were rinsed in PBS 3 times again, and incubated in Avidin-Biotin 
Complex (ABC; Vector Laboratories Vectastain) for 45 minutes, followed by a rinse in PBS 3 
times. For the DAB-nickel reaction, 5 µl of DAB (5% DAB stock), 1000 µl of nickel (5% nickel 
ammonium sulfate stock), and 0.5 µl H2O2 (30% stock) for every ml of PBS was used to 
incubate the brain sections in for 10 minutes on a shaker. Following incubation, the sections 
were rinsed in PBS 3 times and stored in phosphate-buffered saline azide at 4 °C. Afterwards, 
the brain sections were mounted on glass slides with PBS and coverslipped. 
 
Brain imaging 
We conducted a regional analysis of the BNST sections of the brain by imaging them with the 
Axio Imager 2 Research Microscope by the Zeiss Company using the Zen Pro microscope 
software. All brain section images were taken at 10X magnification within a 24-tile area. 
Contrast was set at 1813 for black and 3625 for white. Upon image acquisition, the 24 tiles were 
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stitched together to create one comprehensive image of the brain slice. The left and right BNST 
were selected from this image at 2885 x 2885 units each and saved as TIF files for further cell 
counting analysis. 
 
Cell counting analysis  
 
All brain cell counts were conducted blindly, with the training-testing group of each rat unknown 
to the counter. The number of BNST cell nuclei expressing c-fos protein for each brain was 
quantified using the image processing software ImageJ64 and cross-checked with manual 
counting. The scale for all images was set to 1.550 pixels/µm. The multiple anterior and 
posterior regions within the BNST were partitioned according to their standardized pixel areas 
and template locations. The exact width and height of the BNST areas are specified in Table 2, 
and the BNST templates are illustrated in Figure 4. Each selected region of the BNST was 
copied onto a blank 1000 x 1000 pixel file. The black and white contrast level was set between 
160-170 for the visualization of only black c-fos staining against a white background. This 
setting allowed the ImageJ64 program to count the number of black dots present, thereby 
counting the number of c-fos-positive cells present within that particular region of the BNST.   
15 
	
CHAPTER III 
RESULTS 
 
The freezing behavior in all training and testing groups was analyzed with analysis of variance 
(ANOVA). Levels of freezing in all training sessions were averaged across 1-minute ITls 
between shock-tone pairings (each training session had 5 ITIs). Levels of freezing in all testing 
sessions were averaged across 1-minute blocks (each testing session lasted 10 minutes). It was 
hypothesized that rats tested in proestrus would demonstrate lower levels of freezing, reflecting 
the anxiety-reducing properties of progesterone. However, our data reflected that female rats 
trained in proestrus demonstrated higher levels of fear in testing at a statistically significant 
margin.  
 
Eighty-two female rats in total were trained and tested using either the Pavlovian fear 
conditioning paradigm or the modified control paradigm. Twenty-three rats were excluded due to 
irregular estrous cycles or blood levels that did not match their testing estrous cycles. These 
conditions left our experiment with a total of 59 rats for data analysis. The Shock group 
contained 31 rats and the No-Shock group contained 28 rats. The following group sizes were 
derived from the Shock group: n=7 in Di, Di, n=7 in Pro, Pro, n=10 in Di, Pro, and n=7 in Pro, 
Di. The group sizes for the No-Shock group included: n=8 in Di, Di, n=6 in Pro, Pro, n=7 in Di, 
Pro, and n=7 in Pro, Di. 
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Behavior 
Fear acquisition during training did not differ between Pro and Di Shock groups. For the Pro and 
Di Shock groups in Figure 5A, levels of freezing in all groups were <10% before the initiation of 
tone-shock pairings. While the training session progressed with each trial, freezing increased 
similarly between the two Shock groups, with no statistically significant difference shown in 
percent freezing (p=0.62).  The No-Shock groups remained at normal baseline for the entire 
duration of the training session (<10%; data not shown).   
 
For all four Shock groups, as shown in Figure 5B, no interaction effect was established between 
the estrous cycle stage and fear expression during context testing (p=0.70). However, the training 
state exhibited a statistically significant effect on fear expression (p=0.03). The interaction bar 
plot ANOVA between estrous state and freezing percentage in Figure 5C further illustrates that 
rats trained in proestrus had statistically significant higher levels of freezing than rats trained in 
diestrus (p<0.0001).  No-Shock animals did not exhibit freezing during the context test (data not 
shown). 
 
Progesterone levels at testing 
Assays of plasma progesterone levels after context testing indicated that animals in proestrus had 
significantly higher (p<0.0001) circulating progesterone (50.2 ± 2.3 ng/ml) compared to animals 
in diestrus (10.0 ± 1.0 ng/ml).  
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Cell counts 
Activated cells indicated by c-fos staining were counted for 8 regions or subnuclei of the BNST: 
the oval nucleus (OV), juxtacapsular nucleus (JU), anterolateral nucleus (dorsal portion; ALD), 
anteromedial nucleus (dorsal portion; AMD), anterolateral nucleus (ventral portion; ALV), 
anteromedial nucleus (ventral portion; AMV), fusiform nucleus (FU), and anterolateral nucleus 
(AL). Figures 6 and 7 illustrate a series of bar plot ANOVAs for average quantity of c-fos-
positive cells for all of the No-Shock and Shock groups. Of these 8 brain regions, the OV and JU 
regions (Figure 6A and B) were the only ones that demonstrated a main effect of tone-shock 
training (p=0.003 and p=0.02, respectively), showing overall increased activity as assessed by c-
fos immunoreactivity. The OV nucleus was the only region to show a main effect of estrous 
cycle during context testing, as indicated by increased c-fos expression during diestrus (p=0.03). 
A significant interaction between training, training cycle stage, and testing cycle stage was found 
for the AMD and AMV regions (Figure 7A and B) such that c-fos expression was elevated in 
shocked animals that had been trained and tested in diestrus (p=0.03 and p=0.048, respectively). 
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CHAPTER IV 
CONCLUSION 
 
Our current data suggests that the estrous cycle plays a definitive role in the modulation of the 
acquisition of contextual fear in female rats. In contrast to our original hypothesis, the estrous 
cycle stage did not have a significant effect on fear expression during either training or context 
testing. However, our findings suggest that high levels of progesterone, and possibly high levels 
of its metabolite, ALLO, significantly affect fear acquisition during training to later generate 
greater fear expression in context testing. Furthermore, our c-fos expression analyses of the 
BNST illustrates an increased level of cell activation in the OV, JU, AMD, and AMV regions of 
the BNST as a result of training as well as both training and testing during diestrus, when 
progesterone levels are low. The brain cell analyses also demonstrate a high degree of variation 
in neuronal activation in different BNST areas as a result of contextual fear expression. Given 
the major role ALLO plays in the acquisition of fear in the training state, future studies will be 
conducted to further understand the influence of progesterone throughout the entire duration of 
the Pavlovian fear paradigm. Ultimately, our estrous cycle tracking analyses, behavioral results, 
and blood progesterone level assays suggest that high levels of progesterone may be in part 
responsible for the existent female sex bias in anxiety disorders such as PTSD. This finding, 
discovered within an experimental paradigm using the natural hormonal fluctuations of female 
animal subjects, consequently adds a new layer of complexity to a formerly straightforward 
understanding of the effects of ALLO in relation to anxiety.  
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Previous studies of sex differences in contextual fear have primarily focused on expression of 
fear in females in the Pavlovian fear paradigm without tracking of estrous cycle stage at both 
training and testing (Maren et al., 1994; Barker and Galea, 2010). Furthermore, those studies that 
have taken the estrous cycle into account have involved different training and testing methods 
(Markus and Zecevic, 1997). Previous studies regarding female contextual fear collectively 
suggest that female rats have lower levels of fear than male rats, and that female rats in proestrus 
demonstrate the lowest levels of freezing at testing. A great deal of this behavior has been 
attributed to hormone fluctuations, and ALLO has been suggested to be an important contributor 
to this gender bias (Nagaya et al., 2015). Our study contributes to the previous research done 
with analyzing female fear and the estrous cycle. We report that progesterone may act via its 
metabolite, ALLO, to significantly contribute to the acquisition of context fear such that its 
expression is enhanced. These data contrast with the results of previous studies and support the 
idea that ALLO may have a complex modulatory role in fear acquisition and expression. The 
increased level of c-fos staining observed in the OV and JU subnuclei suggests that training with 
shock selectively activates both anxiogenic (OV) and anxiolytic (JU) subregions of the BNST.  
The increased activation of neurons in the OV as well as those from the anxiolytic AMD and 
AMV regions in Di, Di animals suggests that decreased ALLO levels may result in greater cell 
activation at test although overall fear expression was low. Altogether, these results illustrate that 
the span of ALLO’s effects on fear conditioning is greater than previously imagined.  
 
Moreover, up until recently, many scientific studies utilizing female rats have rendered these 
animals sexless through ovariectomies in order to establish a baseline for hormone analysis 
(Gupta et al., 2001; Maeng et al., 2015). Ovariectomies have historically been preferred due to 
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the extensive degree of estrous stage monitoring required for studies involving cycling female 
rats. Indeed, the usage of intact females in fear conditioning has received little experimental 
attention. However, sudden removal of physiologically relevant processes in any animal can 
potentially change aspects of the studied phenomena itself. Because ovariectomies allow natural 
hormone synthesis and cycling to be bypassed within the body via artificial replacement of 
steroid hormones, it becomes extremely important to consider the validity of the neurological 
and behavioral results these artificial hormones generate. Thus, the results of our experiments 
provide unique and important insight to the way females process and express fear during natural 
hormonal cycle fluctuations. 
 
Taken together, ALLO’s potential influence on the acquisition of fear may play an important role 
in explaining the previous paradox between the apparent immediate anxiety-relieving effects of 
ALLO and the prominence of anxiety disorders in women (who generate naturally higher levels 
of ALLO than men do). ALLO’s fluctuations within the female rat hormonal cycle may at least 
in part account for the anxiety gender bias in females. Other factors to consider include the 
effects other hormones of the estrous cycle have on conditioned fear. For example, deficiencies 
in estrogen have been related to the prevention of fear extinction (Zeidan et al., 2011). Our data 
support the recent hypothesis that hormone fluctuations contribute to anxiety disorders (Donner 
and Lowry, 2013). In relation to clinical applications, ganaxolone, a synthetic version of ALLO, 
is currently being tested for possible treatment for PTSD patients (Pinna, 2014). One must note 
that a significant difference between ganaxolone and progesterone is that while progesterone is 
metabolized relatively quickly by the body, ganaxolone takes far longer for the body to break 
down, subsequently preventing hormone fluctuations of ALLO that possibly lead to anxiety. In 
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light of this, our current findings suggest that new medications encouraging more stable levels of 
ALLO need to be monitored more closely in order to prevent drastic fluctuations of ALLO.  
 
Ultimately, our work suggests that high levels of progesterone, and concomitantly high levels of 
its metabolite ALLO, reduce fear extinction after fear acquisition, allowing for greater fear 
expression in the future. The current relationship between neuronal activation and fear 
expression remains unclear given the high degree of variation among BNST regions. Further 
research will look at progesterone’s neuronal effect in the BNST throughout the entire duration 
of the Pavlovian fear paradigm in order to determine the contributions of different BNST regions 
to conditioned fear.  
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APPENDIX A 
Figure 1 
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Figure 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
26 
	
Table 1 
 
 
 
 
 
 
 
 
 
 
 
Training-Testing Groups 
 
Shock No-Shock 
Proestrus-Proestrus Proestrus-Proestrus 
Proestrus-Diestrus Proestrus-Diestrus 
Diestrus-Proestrus Diestrus-Proestrus 
Diestrus-Diestrus Diestrus-Diestrus 
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Figure 3 
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Figure 4 
 
 
 
 
 
 
 
 
 
130 μm 
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Table 2 
 
 
 
 
 
 
 
 
 
 
 
Standardized BNST Pixel Areas 
BNST 
Anterior 
Width Height BNST 
Posterior 
Width Height 
OV 201.24 522.45 OV 205.11 623.07 
JU 89.01 131.58 JU 77.4 251.55 
FU 263.16 143.19 FU 270.9 170.28 
AMV 344.43 197.37 AMV 445.05 178.02 
AMD 363.78 340.56 AMD 421.83 352.17 
ALD 243.81 100.62 AL 445.05 174.15 
ALV 135.45 154.8 	 	 	
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FIGURE LEGENDS 
Figure 1 
Representative images of wet, unstained vaginal smears taken through each of the 4 stages of the 
rat estrous cycle. Proestrus shows nucleated cells, estrus shows cornified cells, diestrus 1 (also 
called metestrus) shows a mixture of both cell types with the presence of leukocytes, and diestrus 
2 (also called diestrus) predominantly shows leukocytes.  
 
Figure 2 
A schematic pattern of rat progesterone levels in the blood throughout the 4-day rodent estrous 
cycle based on previous studies (Butcher et al., 1974; Smith et al., 1975). Shaded columns at 
diestrus (pink) and proestrus (blue) indicate the lowest and highest levels of progesterone during 
the cycle, respectively. The blue arrow indicates the timing of ovulation. 
 
Figure 3 
A schematic diagram of the Pavlovian fear conditioning experimental design. On the left is 
shown a rat receiving tone-shock pairings in a specific context during training. On the right is 
shown a rat placed in the same context with no tones or shocks during context testing. The 
experimental groups consisted of animals trained and tested during either the same estrous cycle 
phase (Pro, Pro or Di, Di) or different estrous cycle phases (Pro, Di or Di, Pro). 
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Figure 4 
Representative section of the anterior (top left) and posterior (bottom left) portions of the anterior 
BNST stained for c-fos protein. Analysis templates based on the Swanson brain atlas (2003) are 
shown next to their respective brain sections and labeled for BNST nuclei of interest: oval (OV), 
juxtacapsular (JU), fusiform (FU), anteromedial (ventral portion; AMV), anteromedial (dorsal 
portion, AMD), anterolateral (dorsal portion, ALD), anterolateral (ventral portion, ALV), and 
anterolateral (AL). Activated cells (c-fos positive) within each outlined area were counted as part 
of the indicated brain region.  
 
Figure 5 
Conditioned freezing in female rats trained and tested at estrous stages that were either the same 
(Pro, Pro or Di, Di) or different (Pro, Di or Di, Pro). A, Mean percentage of freezing (±SEM) 
during the five-trial training session. Data are shown for a 3-min pre-trial period followed by 5 
tone-shock pairings. Freezing was measured before the first conditioning trial (baseline, BL) and 
for the 1-min period after each conditioning trial. B, Mean percentage of freezing (±SEM) to 
context over 10 min after one complete estrous cycle (Pro, Pro or Di, Di), three estrous cycle 
stages (Pro-Di), or five estrous cycle stages (Di-Pro) after training. C, Mean percentage of 
freezing (±SEM) to context over the complete 10-min test session shown in B for the indicated 
training/testing conditions. 
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Figure 6 
Mean counts (±SEM) per mm2 of c-fos immunopositive cells in different regions of the anterior 
BNST of female rats that were either untrained (No Shock) or trained (Shock) prior to context 
testing. A, oval nucleus (OV). B, juxtacapsular nucleus (JU). C, fusiform nucleus. D, 
anterolateral nucleus. 
 
Figure 7 
Mean counts (±SEM) per mm2 of c-fos immunopositive cells in different regions of the anterior 
BNST of female rats that were either untrained (No Shock) or trained (Shock) prior to context 
testing. A, anteromedial nucleus, ventral portion (AMV). B, anteromedial nucleus, dorsal portion 
(AMD). C, anterolateral nucleus, ventral portion (ALV). D, anterolateral nucleus, dorsal portion 
(ALD). 
 
 
 
 
